Northwestern Medicine scientists have discovered a genetic basis for glaucoma symptoms and the impact of other genes in early retinal development.
Northwestern Medicine scientists and collaborators discovered that mutations in the TEK gene lead to primary congenital glaucoma, validating previous findings in mice and suggesting a target for future therapies.
Nicholas Volpe, MD, chair of Ophthalmology and George and Edwina Tarry Professor of Ophthalmology, was recently accepted into the American Ophthalmological Society.
Third-year medical students participated in an ophthalmology clinical skills session to learn more about the diagnosis, treatment and prevention of diseases of the eye.
The Department of Ophthalmology has received an $115,000 unrestricted grant from Research to Prevent Blindness to support research into the causes, treatment and prevention of blinding diseases.
A randomized clinical trial showed an intravitreous drug may be an alternative treatment for some patients with proliferative diabetic retinopathy.
Gregory Schwartz, PhD, assistant professor of Ophthalmology and Physiology, and his lab map neural circuits in the retina that send visual information to the brain, work that could inform future treatments for blindness.
A team of Northwestern University students and faculty launched a start-up, Opticent Health, which recently received an award from the National Science Foundation to bring their technology innovation to the market.
A new Northwestern Medicine study published in the New England Journal of Medicine shows the drug Eylea is superior to other options for improving the eyesight of persons with poor vision due to diabetic macular edema, a major cause of diabetes-related vision loss.
Research to Prevent Blindness (RPB) has awarded a grant to the Department of Ophthalmology to support research into the causes, treatment and prevention of blinding diseases.